Credit Agreement with Bank of America, N.A.
On April 3, 2020, South Jersey Industries, Inc. (the “Company”)
entered into an unsecured $200 million term loan credit agreement (the “Credit Agreement”) with Bank of America, N.A. (“Bank of America”), as administrative agent and the lender. The entire amount was borrowed on April 3, 2020, and the
Company used the net proceeds of the borrowing to repay three previous credit agreements: (a) that certain 364-day Revolving Credit Agreement
dated as of September 7, 2016, as amended, among the Company, Morgan Stanley Bank, N.A., and Morgan Stanley Senior Funding, Inc., as the Administrative Agent; (b) that certain Term Loan Credit Agreement dated as of October 28, 2015 among the
Company, the lenders party thereto from time to time, and Bank of America; and (c) that certain Term Loan Credit Agreement dated as of September 23, 2019 among the Company, the lenders party thereto from time to time, and Bank of America.
The maturity date of the term loan is October 31, 2021, at which time the principal and any accrued but unpaid interest must be paid. Any amounts repaid prior to the maturity date cannot be reborrowed.
The term loan bears interest at a variable base rate or a variable London Interbank Offered Rate (“LIBOR”), at the Company’s
election. Interest on base rate loans will be equal to the highest of: (a) the Federal Funds Rate plus 0.5%; (b) the daily “prime rate” of Bank of America; and (c) the one-month LIBOR rate plus 1%; plus in each case, an applicable margin that may
range from 0.40% to 1.30%, depending on the Company’s Debt Rating (as defined in the Credit Agreement). Interest on LIBOR loans will be determined by reference to LIBOR plus an applicable margin that may range from 1.40% to 2.30%, depending on the
Company’s Debt Rating.
The Credit Agreement contains customary representations, warranties and covenants, including a financial covenant limiting the ratio of Indebtedness
of the Company and its subsidiaries on a consolidated basis to Consolidated Total Capitalization (as such terms are defined in the Credit Agreement) of not more than 0.70 to 1.0, and customary events of default.
Bank of America and its affiliates have in the past performed, and may in the future from time to time perform, investment banking, financial
advisory, lending or commercial banking services or other services for the Company or its affiliates, and affiliates of Bank of America have served in the past as underwriters in public offerings of securities by the Company or its affiliates, for
which they have received, and may in the future receive, customary compensation and expense reimbursement.
A copy of the Credit Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 1.01. The
foregoing summary of the Credit Agreement is qualified in its entirety by reference to the text of the Credit Agreement filed as Exhibit 10.1 to this Current Report on Form 8 K.
ATM Equity Offering Sales Agreement
On April 6, 2020, the Company entered into an ATM Equity Offering Sales Agreement (the “Sales Agreement”) with BofA Securities, Inc. and Wells Fargo Securities, LLC, each as sales agent, and/or principal (each, a “Sales Agent”) to sell, from time to time, shares of the
Company’s common stock, par value $1.25 per share (“Common Shares”), having an aggregate sale price up to $200,000,000, through an “at-the-market” equity offering program. The Company filed a prospectus supplement, dated April 6, 2020, with the Securities and Exchange Commission in connection
with the offer and sale of the Common Shares being sold under the program. The Company intends to use the net proceeds from this offering, after deducting the Sales Agents’ commissions and related offering expenses payable by the Company,
for general corporate purposes.
Pursuant to the Sales Agreement, the Common Shares may be offered and sold through any of the Sales Agents in negotiated
transactions or transactions that are deemed to be “at-the-market” offerings as defined in Rule 415 of the Securities Act of 1933, as amended, including sales made by means of ordinary brokers’ transactions on or through the New York Stock
Exchange or another national securities exchange, or otherwise, at market prices prevailing at the time of sale, at prices related to prevailing market prices or negotiated transactions, or as otherwise agreed with the applicable Sales Agent.
The Sales Agreement provides that each Sales Agent will be entitled to compensation of up to 2.0% of the gross sales price of
the Common Shares sold through such Sales Agent. The Company may also sell Common Shares to a Sales Agent as principal for its own account, at a price and discount to be agreed upon at the time of sale pursuant to a separate terms agreement.
If the Company sells Common Shares to a Sales Agent as principal, the Company will enter into a separate terms agreement with such Sales Agent and the Company will describe the agreement in a separate prospectus supplement or pricing
supplement.
The Common Shares will be initially issued pursuant to the Company’s shelf registration statement on Form S-3 (File No.
333-233669). Prior to the expiration of such registration statement, the Company will file a successor automatic shelf registration statement on Form S-3. Subsequent issuances of the Common Shares will be made pursuant to the Company’s
successor registration statement.
The Company has no obligation to sell any of the Common Shares under the Sales Agreement and may at any time suspend solicitation
and offers under the Sales Agreement.
The Sales Agents and/or their respective affiliates have engaged in, and/or may in the future engage in, investment banking,
commercial banking, financial advisory and/or other commercial dealings in the ordinary course of business with the Company and/or the Company’s subsidiaries, for which they have received and/or in the future may receive fees and commissions for
these transactions or services.
The foregoing description of the Sales Agreement is a summary and is qualified in its entirety by reference to the Sales
Agreement, which is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.
In connection with the filing of the prospectus supplement, Melissa
Orsen, Senior Vice President and General Counsel, delivered her legality opinion with respect to the Common Shares to be issued pursuant to the Sales Agreement. A copy
of the legality opinion is attached hereto as Exhibit 5.1 and is incorporated herein by reference.